QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:DEN

Denbury (DEN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$88.66
$88.66
50-Day Range
$88.56
$97.10
52-Week Range
$75.33
$100.65
Volume
N/A
Average Volume
1.01 million shs
Market Capitalization
$4.56 billion
P/E Ratio
9.90
Dividend Yield
N/A
Price Target
$93.33

Denbury MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
5.3% Upside
$93.33 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Denbury in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
19.18%
From $5.58 to $6.65 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.25 out of 5 stars

DEN stock logo

About Denbury Stock (NYSE:DEN)

Denbury Inc. operates as an independent energy company in the Gulf Coast and Rocky Mountain regions. It holds interests in various oil and natural gas properties located in Mississippi, Texas, and Louisiana in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. The company was formerly known as Denbury Resources Inc. and changed its name to Denbury Inc. in September 2020. Denbury Inc. was founded in 1951 and is headquartered in Plano, Texas.

DEN Stock News Headlines

The recent rise of single-storey living
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Villagers face 15 mile diversion due to 'essential works'
DENBURY GATHERING & MARKETING INC's Net Worth
See More Headlines
Receive DEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Denbury and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/03/2023
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Energy
Industry
Oil & Gas E&P
Sub-Industry
N/A
Employees
793
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$93.33
High Stock Price Target
$96.00
Low Stock Price Target
$91.00
Potential Upside/Downside
+5.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$480.16 million
Pretax Margin
39.50%

Debt

Sales & Book Value

Annual Sales
$1.48 billion
Cash Flow
$10.43 per share
Book Value
$30.77 per share

Miscellaneous

Free Float
51,375,000
Market Cap
$4.56 billion
Optionable
Not Optionable
Beta
2.41
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Christian S. Kendall (Age 56)
    President, CEO & Director
    Comp: $2.03M
  • Mr. Mark C. Allen CPA (Age 55)
    Executive VP, CFO, Treasurer & Assistant Secretary
    Comp: $1.52M
  • Mr. David E. Sheppard (Age 51)
    Executive VP & COO
    Comp: $1.04M
  • Mr. James Stanley Matthews (Age 61)
    Executive VP, Chief Administration Officer, General Counsel & Secretary
    Comp: $1.2M
  • Ms. Nicole H. Jennings (Age 47)
    VP & Chief Accounting Officer
  • Mr. Matthew W. Dahan (Age 59)
    Senior Vice President of Business Development & Technology
  • Mr. Brad Whitmarsh
    Executive Director of Investor Relation
  • Ms. Jenny Cochran (Age 54)
    Senior Vice President of Business Services
  • Mr. Nikulas J. Wood (Age 43)
    Senior Vice President – CCUS

DEN Stock Analysis - Frequently Asked Questions

Should I buy or sell Denbury stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Denbury in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DEN, but not buy additional shares or sell existing shares.
View DEN analyst ratings
or view top-rated stocks.

What is Denbury's stock price target for 2024?

5 analysts have issued 1 year price targets for Denbury's stock. Their DEN share price targets range from $91.00 to $96.00. On average, they expect the company's share price to reach $93.33 in the next year. This suggests a possible upside of 5.3% from the stock's current price.
View analysts price targets for DEN
or view top-rated stocks among Wall Street analysts.

How were Denbury's earnings last quarter?

Denbury Inc. (NYSE:DEN) released its quarterly earnings results on Thursday, August, 3rd. The company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by $0.17. The company had revenue of $328.98 million for the quarter, compared to analyst estimates of $345.83 million. Denbury had a trailing twelve-month return on equity of 19.82% and a net margin of 32.34%. The business's quarterly revenue was down 31.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.69 earnings per share.

What ETFs hold Denbury's stock?

ETFs with the largest weight of Denbury (NYSE:DEN) stock in their portfolio include Invesco Dorsey Wright Energy Momentum ETF (PXI) and Invesco DWA SmallCap Momentum ETF (DWAS).First Trust Nasdaq Oil & Gas ETF (FTXN).

This page (NYSE:DEN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners